Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors.
Rosen EY, Schram AM, Young RJ, Schreyer MW, Hechtman JF, Shu CA, Ku NC, Hyman DM, Drilon A.
Rosen EY, et al. Among authors: schreyer mw.
JCO Precis Oncol. 2019 May 16;3:PO.19.00009. doi: 10.1200/PO.19.00009. eCollection 2019.
JCO Precis Oncol. 2019.
PMID: 32914009
Free PMC article.
No abstract available.